Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

Clinical trial NCT03201458 · COMPLETED

Trial details

NCT number: NCT03201458
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gallbladder Carcinoma Metastatic Cholangiocarcinoma Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Unresectable Cholangiocarcinoma

Start date: 2018-02-08
Primary completion: 2020-08-07
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.